34 results on '"Talayero, Paloma"'
Search Results
2. 407.1: Experimental Assay of Intestinal Graft Viability and Function After Regional Abdominal Normothermic Perfusion
3. 317.8: Antibody-Removal Therapies in Pediatric Intestinal and Multivisceral Recipients: Why, When and How? A Single-Center Experience
4. 317.7: qPCR Based Immunotherapy in Intestinal Transplant Recipients and Candidates
5. IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection
6. Preclinical Study of DCD and Normothermic Perfusion for Visceral Transplantation
7. 46: The fall of a myth: the first three cases of DCD in intestinal transplantation
8. 63: DCD in intestinal transplantation: the path to prove its validity in both experimental and clinical models
9. 5-gene differential expression predicts stability of human intestinal allografts
10. CLINICAL-EXPERIMENTAL EXPERIENCE WITH RAPAMYCIN IN VISCERAL TRANSPLANTATION
11. PEDIATRIC INTESTINAL RETRANSPLANTATION: OUTCOMES IN A REFERAL CENTER
12. Immune response in an experimental model of pig to rabbit abdominal fascia transplantation.
13. Antibody-removal therapies for de novo DSA in pediatric intestinal recipients: Why, when, and how? A single-center experience
14. Experimental Assessment of Intestinal Damage in Controlled Donation After Circulatory Death for Visceral Transplantation
15. First case report of multivisceral transplant from a deceased cardiac death donor
16. Helper Innate Lymphoid Cells (hILC) resist Immunosuppressive Therapy: an Observation from Kidney and Liver Transplantation
17. Early renal graft function deterioration in recipients with preformed anti-MICA antibodies: partial contribution of complement-dependent cytotoxicity
18. Delayed introduction of sirolimus in paediatric intestinal transplant recipients: indications and long‐term benefits
19. Toward Sézary Syndrome immunotherapy
20. Graft infusion of adipose‐derived mesenchymal stromal cells to prevent rejection in experimental intestinal transplantation: A feasibility study
21. IL-6–based mortality risk model for hospitalized patients with COVID-19
22. Novel coronavirus (SARS‐CoV‐2) infection in a patient with multivisceral transplant
23. Donor helper innate lymphoid cells are replaced earlier than lineage positive cells and persist long‐term in human intestinal grafts – a descriptive study
24. Number and function of circulatory helper innate lymphoid cells are unaffected by immunosuppressive drugs used in solid organ recipients – a single centre cohort study
25. P4.46: PEDIATRIC INTESTINAL RETRANSPLANTATION: OUTCOMES IN A REFERAL CENTER
26. P4.12: Immune response in an experimental model of pig to rabbit abdominal fascia transplantation.
27. Donor‐Specific Antibodies in Pediatric Intestinal and Multivisceral Transplantation: The Role of Liver and Human Leukocyte Antigen Mismatching
28. Novel coronavirus (SARS‐CoV‐2) infection in a patient with multivisceral transplant.
29. 5-gene differential expression predicts stability of human intestinal allografts
30. High proportion of CD95+ and CD38+ in cultured CD8+ T cells predicts acute rejection and infection, respectively, in kidney recipients
31. Early renal graft function deterioration in recipients with preformed anti-MICA antibodies: partial contribution of complement-dependent cytotoxicity
32. High Proportion of Pretransplantation Activated Regulatory T cells (CD4+CD25highCD62L+CD45RO+) Predicts Acute Rejection in Kidney Transplantation
33. High Proportion of Pretransplantation Activated Regulatory T cells (CD4+CD25highCD62L+CD45RO+) Predicts Acute Rejection in Kidney Transplantation.
34. Perforin gene variant A91V in young patients with severe COVID-19.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.